Inhibition of Tau Phosphorylation as a Potential Strategy in Treatment of Parkinson’s Disease

Codice QR

Inhibition of Tau Phosphorylation as a Potential Strategy in Treatment of Parkinson’s Disease

None

Salvato in:

Dettagli Bibliografici
Autore principale:	Wenya, Wang
Natura:	Elettronico Capitolo di libro
Lingua:	inglese
Pubblicazione:	IntechOpen 2011
Soggetti:	Health Sciences
Accesso online:	https://www.intechopen.com/chapters/22883
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Tau Oligomers as Potential Drug Target for Alzheimer Disease (AD) Treatment
di: Kayed, Rakez
Pubblicazione: (2011)

The Potential of Neurotrophic Factors for the Treatment of Parkinson’s Disease
di: Sullivan, Aideen M., et al.
Pubblicazione: (2011)

Isoforms of Phosphorylated Tau as Potential Biomarkers for Alzheimer’s Disease: The Contribution of Mass Spectrometry-Based Proteomics
di: Marco Agostini, et al.
Pubblicazione: (2025-06-01)

Hypergravity and ERK Inhibition Combined Synergistically Reduce Pathological Tau Phosphorylation in a Neurodegenerative Cell Model
di: Valerio Mignucci, et al.
Pubblicazione: (2025-07-01)

Therapeutic Potential of Polyphenols in Parkinson’s Disease
di: Mythri, Rajeswara Babu, et al.
Pubblicazione: (2011)

Dopaminergic Control of the Neurotransmitter Release in the Subthalamic Nucleus: Implications for Parkinson’s Disease Treatment Strategies
di: Ampe, Ben, et al.
Pubblicazione: (2011)

Inhibition of Thrombin as a Novel Strategy in the Treatment of Scleroderma-Associated Interstitial Lung Disease
di: Bogatkevich, Galina S., et al.
Pubblicazione: (2012)

Consequences of Mitochondrial Dysfunction in Huntington's Disease and Protection via Phosphorylation Pathways
di: Cunha-Oliveira, Teresa, et al.
Pubblicazione: (2012)

Genetics of Parkinson Disease
di: Sassi, Celeste
Pubblicazione: (2011)

Parkin and Parkinson’s Disease
di: Tay, Shiam-Peng, et al.
Pubblicazione: (2011)

Update in Parkinson’s Disease
di: Carrillo, Fátima, et al.
Pubblicazione: (2012)

Cross‐sectional study of plasma phosphorylated tau 217 in persons without dementia
di: Toni T. Saari, et al.
Pubblicazione: (2025-04-01)

The Execution Step in Parkinson’s Disease – On the Vicious Cycle of Mitochondrial Complex I Inhibition, Iron Dishomeostasis and Oxidative Stress
di: Núñez, Marco T., et al.
Pubblicazione: (2012)

CFS Biomarkers in Parkinson’s Disease
di: Parnetti, Lucilla, et al.
Pubblicazione: (2011)

Imaging Dyskinesias in Parkinson’s Disease
di: Politis, Marios, et al.
Pubblicazione: (2011)

Cognitive Dysfunction in Parkinson’s Disease
di: Varanese, Sara, et al.
Pubblicazione: (2011)

Gastrointestinal Dysfunction in Parkinson’s Disease
di: Krogh, Klaus
Pubblicazione: (2011)

Etiology and Pathogenesis of Parkinson’s Disease
di: Hatano, Taku, et al.
Pubblicazione: (2011)

Gene Therapy for Parkinson’s Disease
di: Douglas, Michael, et al.
Pubblicazione: (2011)

Timing Control in Parkinson’s Disease
di: Almeida, Quincy J.
Pubblicazione: (2012)

Parkinson’s Disease and the Immune System
di: Ward1, Roberta J., et al.
Pubblicazione: (2012)

Role of FKBPs in Parkinson’s Disease
di: Chattopadhaya, Souvik, et al.
Pubblicazione: (2012)

Dopamine Transporter Imaging for Distinguishing Between Idiopathic Parkinson’s Disease and Secondary Parkinsonism
di: Huang, Chin-Chang, et al.
Pubblicazione: (2012)

Wading into a Theoretical Model for Parkinson's Disease
di: Verzi, Diana W.
Pubblicazione: (2012)

Diagnosis and Differential Diagnosis of Parkinson’s Disease
di: Lingor, Paul, et al.
Pubblicazione: (2011)

How to Stay Active with Parkinson’s Disease
di: Qutubuddin, Abu
Pubblicazione: (2011)

Cognition and Gait Disturbances in Parkinson's Disease
di: Ribarič, Samo
Pubblicazione: (2011)

Nocturnal Disturbances in Patients with Parkinson’s Disease
di: Suzuki, Keisuke, et al.
Pubblicazione: (2011)

Neuropsychological Deficits in Initial Parkinson’s Disease
di: Fernandez, Raquel Rodriguez, et al.
Pubblicazione: (2011)

Cognitive and Psychiatric Aspects of Parkinson’s Disease
di: Stephani, Caspar
Pubblicazione: (2011)

The Negative Impact of Apathy in Parkinson’s Disease
di: Leroi, Iracema
Pubblicazione: (2011)

Analysis of Transcriptome Alterations in Parkinson’s Disease
di: Filatova, Elena, et al.
Pubblicazione: (2011)

Inflammatory Responses and Regulation in Parkinson’s Disease
di: Peterson, Lynda J., et al.
Pubblicazione: (2011)

Successes of Modelling Parkinson Disease in Drosophila
di: Staveley, Brian E.
Pubblicazione: (2012)

Acetyl-L-Carnitine in Parkinson’s Disease
di: Sinicropi, Maria Stefania, et al.
Pubblicazione: (2012)

Inflammation in Parkinson’s Disease: Causes and Consequences
di: Collins, Louise M., et al.
Pubblicazione: (2012)

Pathological Stages of Abnormally Processed Tau Protein During Its Aggregation into Fibrillary Structures in Alzheimer’s Disease
di: García-Sierra, Francisco, et al.
Pubblicazione: (2011)

The Noradrenergic System is a Major Component in Parkinson’s Disease
di: Szot, Patricia, et al.
Pubblicazione: (2011)

The Energy Crisis in Parkinson’s Disease: A Therapeutic Target
di: Abou-Hamdan, Mhamad, et al.
Pubblicazione: (2011)

Botulinum A Toxin Intravesical Injections in the Treatment of Refractory Overactive Bladder in Patients with Parkinson's Disease
di: Giannantoni, Antonella, et al.
Pubblicazione: (2011)